TB-500: Effects, Dosage & Research

Q: What is the difference between TB-500 and BPC-157?

TB-500 (Thymosin Beta-4 fragment) works systemically, promoting angiogenesis and actin regulation throughout the body. BPC-157 originates from gastric juice and shows strong local tissue-protective effects especially in the gut. They are often combined for synergistic recovery protocols.

Q: How long until TB-500 shows effects?

Research and community reports suggest initial effects may be observed within 2-4 weeks. Structural tissue repair may require 6-12 weeks of consistent protocol.

Q: Can TB-500 be combined with BPC-157?

The TB-500 + BPC-157 combination is one of the most documented peptide stacks in recovery research. The two peptides appear to work via complementary mechanisms: TB-500 provides systemic regenerative signalling and BPC-157 offers local tissue protection.

What is TB-500?

TB-500 is the synthetic peptide matching the actin-binding domain of Thymosin Beta-4 (Tβ4), a protein found in nearly every cell in the body. The active fragment, typically the sequence Ac-LKKTETQ, drives many of Thymosin Beta-4's effects, in particular its regulation of actin polymerisation and its promotion of cell migration.

Thymosin Beta-4 was first identified by Allan Goldstein at George Washington University, who has published on thymic peptides since the 1960s. Research on TB-500 has since spread into wound healing, cardiac repair, neurological models and hair growth, so it now appears across a wide span of the recovery literature.

This article covers what the peer-reviewed research shows, plus what is documented about dosage and administration.

Effects, what does the research say?

Most TB-500 studies are in animals, with some early human and in vitro data. The work is generally solid and has been reproduced across several labs. The recurring finding is that TB-500 promotes cell migration, reduces inflammation and stimulates new blood-vessel formation, all through its interaction with actin.

Injury Recovery & Tissue Repair

TB-500's most-documented effect is faster tissue healing. By binding actin and promoting cell migration, it speeds the closure of wounds, repair of muscle fibres and healing of connective tissue.

Study (2004): Thymosin β4 promotes dermal healing and reduces scar formation in animal wound models PubMed 16607611 ↗
Study (2002): Thymosin β4 promotes corneal repair after injury, demonstrating tissue-specific healing acceleration PubMed 20536453 ↗
Likely mechanism: upregulates matrix metalloproteinases (MMPs), promotes keratinocyte and endothelial cell migration, and modulates actin dynamics

"Thymosin β4 is a ubiquitous, highly conserved, G-actin sequestering protein with multiple functions in addition to its primary role as the main intracellular G-actin sequestering molecule ... It is present in high concentrations in most mammalian cells and has been reported to promote wound healing, cardiac repair, and to have anti-inflammatory properties."

Allan L. Goldstein, George Washington University · Goldstein et al. (2005), Annals of the New York Academy of Sciences, PMID 16099219 ↗

Anti-Inflammatory Properties

TB-500 shows anti-inflammatory action across research models. It downregulates pro-inflammatory cytokines and appears to modulate the NF-κB pathway, which drives much of the body's inflammatory response. That makes it relevant to models of chronic inflammation and autoimmune-adjacent conditions.

Reduces inflammatory markers in multiple tissue types including cardiac, corneal, and dermal models
Demonstrated anti-inflammatory activity independent of its actin-binding function
Potential relevance to neuroinflammation models (early-stage research)

Cardiac Repair Research

A well-studied area of TB-500 research is cardiac regeneration. In animal studies, Thymosin Beta-4 promotes cardiomyocyte survival and mobilises cardiac progenitor cells after myocardial injury.

Study (2004): Thymosin β4 activates integrin-linked kinase (ILK) and promotes cardiomyocyte survival after ischaemia, representing a potential target for cardiac repair PubMed 15565145 ↗
Cardioprotective signalling via ILK/Akt pathways has been reproduced in several studies

"We demonstrate that thymosin β4 promotes cardiomyocyte and endothelial cell survival and induces angiogenesis by activating integrin-linked kinase (ILK) ... These results suggest that thymosin β4 is a potential therapeutic agent for the treatment of ischemic heart disease."

Philp D et al. (2006) · Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. Journal of Cellular Physiology · PMID 16607611 ↗

Hair Growth Research

A newer area of TB-500 research is hair-follicle activation. Thymosin Beta-4 is expressed in hair-follicle stem cells and appears to regulate the switch between the resting (telogen) and active-growth (anagen) phases. In animal studies, local application promotes follicle cycling.

Thymosin β4 activates quiescent hair follicle stem cells and promotes transition to the anagen phase
Research interest in alopecia models, though human clinical data remains limited

Dosage, what is being researched?

Important: There is no officially approved human dosage for TB-500. The following reflects what is documented in published research and what research communities report; this is not medical advice.

Goal	Typical Dose	Protocol	Duration
Acute injury / loading	2-2.5 mg twice weekly	Subcutaneous injection	4-6 weeks
Maintenance / recovery	2 mg once weekly	Subcutaneous injection	6-12 weeks
Combined with BPC-157	2 mg TB-500 + 250-500 mcg BPC-157	Separate injections, 2-3x weekly	6-8 weeks

Important Notice: TB-500 is not an approved pharmaceutical. Use is at your own risk. Consult a physician before use. Legal status varies by country, so always check local regulations.

Storage & Reconstitution

Unreconstituted: Refrigerator (2-8 °C), protected from light, shelf life up to 24 months
After reconstitution with bacteriostatic water: max. 30 days refrigerated
Do not freeze after reconstitution, peptide chains can be damaged
Add water slowly along the glass wall, do not shake
TB-500 is a larger peptide than BPC-157, ensure full dissolution before use

Frequently Asked Questions

Is TB-500 legal in Thailand?

Research peptides are sold openly in Thailand for laboratory research. They are not approved by the Thai FDA as therapeutics for human consumption. We sell strictly for research use; by purchasing you confirm you will use the product accordingly.

Does TB-500 require injection or can it be taken orally?

TB-500 is typically administered via subcutaneous injection for systemic effects. Oral bioavailability is considered negligible; like most peptides, TB-500 is broken down in the digestive system before it reaches the bloodstream in meaningful amounts.

What is the difference between TB-500 and BPC-157?

TB-500 (Thymosin Beta-4 fragment) works systemically, acting on actin dynamics and promoting angiogenesis throughout the body. BPC-157 originates from gastric juice and shows strong local tissue-protective effects, particularly in the gut and connective tissue. Their mechanisms are complementary, which is why the combination is widely studied.

How long until TB-500 shows effects?

Published research and community data suggest initial observable changes in 2-4 weeks of consistent use. For structural tissue repair (tendons, muscle), the typical research window is 6-12 weeks.

Can TB-500 be combined with BPC-157?

The TB-500 + BPC-157 stack is one of the most-studied peptide combinations in recovery research. The two appear to work through complementary pathways: TB-500 drives systemic regenerative signalling and angiogenesis, while BPC-157 provides local tissue protection and growth-factor upregulation. Research interactions carefully before combining compounds.

Ready to order TB-500?Janoshik-tested · Ships same-day from Bangkok

View in Shop →